Table 1.

Medicines optimisation services provided by community pharmacies in England and Wales

Service	Medicine use review (MUR)	New medicine service (NMS)
Which patients?	70% must be targeted towards specified patient disease groups (not including cancer). The remainder may be carried out with any other patient [9]. They must be carried out in the patients usual community pharmacy [9]	Patients prescribed new medicines for specified long-term conditions [10]
Method of delivery	One consultation, usually face-to-face but telephone possible with relevant permissions [9]	Patient can choose face to face or telephone delivery. Up to three consultations: Initial advice, intervention and follow-up consultations usually by telephone [10]
Use in patients with cancer	Research indicates rarely provided [11]	Cancer not one of the specified long-term conditions [10]
Reimbursement	£28 [9]	Between £20 and £28 depending on number provided [10]